Cyberknife Radiosurgery Brain Tumor Treatment cost in India

Search Here

Cyberknife Radiosurgery Brain Tumor Treatment cost in India

service

Cyberknife Radiosurgery Brain Tumor Treatment cost in India

Cyberknife Brain Tumor Treatment cost in India is 7000 USD with 5 sessions (approx) with 1-2 days hospital stay. CyberKnife radiation therapy treats all types of brain tumours very accurately, Our thousands plus patients suffering from brain tumors have been treated using CyberKnife radiotherapy treatment while maintaining good quality of life.

CyberKnife technology uses radiation to ablate brain tumors and prevent them from growing.

The exact pinpoint accuracy of CyberKnife also minimizes damage to surrounding healthy tissue , which can be a problem with standard radiation treatment.

Ideal Candidate for CyberKnife?

People they are not a good candidate for surgery, because a tumor is in a dangerous area of the brain, may be a good candidate for CyberKnife Brain Cancer Treatment.

Expect from CyberKnife Radiosurgery Brain Tumour Treatment?

Patients can be treated in 1 to 5 treatments sessions over a period of few days.

The treatment itself is comfortable , and patients can expect little or no side effects after undergoing CyberKnife treatment.

Different Types of Brain Tumors can CyberKnife Radiosurgery Treat?

Whether benign, such as meningiomas, acoustic neuromas, pituitary adenomas, and cavernous angiomas or Primary , such as persistent/recurring glioblastomas or astrocytomas (Astrocytoma is a type of cancer that can occur in the brain or spinal cord) or metastatic tumors , Cyberknife treat them all with great success rate.

CyberKnife Also known as Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiosurgery (SRS), this cutting-edge radiation technology is completely non-invasive.

There is no cutting , incision, blood , anesthesia, or pain. There are few , if any side effects and no recovery time. You can resume your normal activities immediately following treatment. Each treatment sessions takes about upto 45 minutes. Patients typically require only one to five treatments sessions instead of 10 or more treatments with conventional radiation treatment. If tumors come back, Cyberknife can treat them again. The CyberKnife radiosurgery system can be used either or a stand-alone basis or in combination with other brain cancer or whole -brain radiation therapy.

Unlike other radiotherapy systems- such as the Gamma Knife system- the CyberKnife system does not require patients to be fitted with a rigid and invasive head frame and is done on an outpatient basis. In the set-up stage, the radiation oncologists will create a soft mesh mask that is custom fitted to the patient's face. This comfortable and non-invasive mask helps keep the patient's head and neck still during treatment.

While wearing the mask, a CT scan will be performed . The CT scan data will be used by the CyberKnife team to determine the exact size, shape and location of the tumor.

The doctors team will determine the size of the area that must be targeted by radiation and the appropriate radiation dose.

The CyberKnife system will move slowly around you during treatment and you won't feel anything. It is completely pain less. Patients dress comfortably in their own cloths and can bring music to listen to during treatment. Nothing will be required of the patient , except relaxation . In fact, patients often sleep through the treatment.

There are generally only very minimum side effects from CyberKnife radiosurgery Treatments , which may include mild headache and fatigue.

After completing the CyberKnife radiosurgery treatment, Patients will schedule follow-up appointments.

Please note:  That the brain tumor will not suddenly disappear. It could take 6-8 weeks or months for the full effect of the treatment to be known.

Response to treatment varies from patients to patients. Medical experience has shown the most brain cancer patients responding positive to CyberKnife radiosurgery treatments.

CyberKnife radiosurgery treatment has been used for more than three decades with extremely high success rates of tumor control, and most patients are good candidates for treatment.

Read Our Latest Post